Table 5.
Outcomes on patients who had prior surgery
| MVD | MVD + ablative | Single ablative | Multiple ablatives | P | |
|---|---|---|---|---|---|
| n | 13 | 8 | 15 | 13 | |
| Drug at MDT | |||||
| Monotherapy | 7 (58.3) | 5 (62.5) | 6 (42.9) | 7 (53.8) | 0.799 |
| Polytherapy | 5 (41.7) | 3 (37.5) | 8 (57.1) | 6 (46.2) | |
| No further surgery | 8 (61.5) | 3 (37.5) | 9 (60.0) | 6 (46.2) | 0.639 |
| Further surgery | 5 (38.5) | 5 (62.5) | 6 (40.0) | 7 (53.8) | |
| MVD | 2 (40.0) | 0 (0.0) | 3 (50.0) | 4 (57.1) | 0.327 |
| SRS | 1 (20.0) | 0 (0.0) | 0 ( 0.0) | 0 ( 0.0) | |
| GLYC | 1 (20.0) | 2 (40.0) | 0 ( 0.0) | 1 (14.3) | |
| RFT | 1 (20.0) | 3 (60.0) | 3 (50.0) | 2 (28.6) | |
| Pain status at last visit | |||||
| Pain free | 7 (53.8) | 2 (25.0) | 3 (21.4) | 5 (38.5) | 0.341 |
| Mild | 2 (15.4) | 4 (50.0) | 2 (14.3) | 4 (30.8) | |
| Moderate | 4 (30.8) | 2 (25.0) | 8 (57.1) | 4 (30.8) | |
| Severe | 0 (0.0) | 0 (0.0) | 1 (7.1) | 0 (0.0) | |
| Drug at last visit | |||||
| No drugs | 4 (30.8) | 2 (25.0) | 1 (6.7) | 4 (30.8) | 0.383 |
| Monotherapy | 7 (53.8) | 3 (37.5) | 7 (46.7) | 7 (53.8) | |
| Polytherapy | 2 (15.4) | 3 (37.5) | 7 (46.7) | 2 (15.4) | |
| Complications | |||||
| No | 9 (69.2) | 6 (75.0) | 12 (80.0) | 8 (61.5) | 0.146 |
| Numbness | 1 (7.7) | 2 (25.0) | 0 (0.0) | 5 (38.5) | |
| Anaesthesia dolorosa | 1 (7.7) | 0 (0.0) | 2 (13.3) | 0 (0.0) | |
| Others | 2 (15.4) | 0 (0.0) | 1 (6.7) | 0 (0.0) | |
Missing pain status for one patient
MVD Microvascular decompression, SRS Stereotactic radiosurgery, GLYC Glycerol rhizotomy, RFT Radiofrequency thermocoagulation